Magnetic nanoparticles (MNPs) have been extensively explored as magnetic resonance
imaging (MRI) contrast agents. With the increasing complexity in the structure of modern …

Ferrimagnetic iron oxide nanoparticles (magnetite or maghemite) have been the subject of
an intense research, not only for fundamental research but also for their potentiality in a …

Iron oxide nanoparticle (IONP) with unique magnetic property and high biocompatibility
have been widely used as magnetic resonance imaging (MRI) contrast agent (CA) for long …

Magnetic Resonance Imaging (MRI) is a powerful, noninvasive and nondestructive
technique, capable of providing three-dimensional (3D) images of living organisms. The use …

Ultrasmall iron oxide nanoparticles have recently attracted much attention as T1 (positive)
contrast agents for magnetic resonance imaging to serve as safer alternatives to gadolinium …

Research on iron oxide-based magnetic nanoparticles and their clinical use has been, so
far, mainly focused on the spherical shape. However, efforts have been made to develop …

Clustering of magnetic nanoparticles (MNPs) is perhaps the most effective, yet intriguing
strategy to enhance T 2 relaxivity in magnetic resonance imaging (MRI). However, the …

Multimodal imaging strategies integrating manifold images have improved our ability to
diagnose, to guide therapy, and to predict outcomes. Magnetic resonance imaging (MRI) is …

The superparamagnetic magnetite nanoparticles have broad application prospects in the
diagnosis and treatment of cancer. Herein, a series of monodispersed exceptionally small …

To achieve the accurate diagnosis of tumor with the magnetic resonance imaging (MRI),
nanomaterials‐based contrast agents are developed rapidly. Here, a tumor targeting …